TY - JOUR
T1 - Valuing innovative endoscopic techniques
T2 - prophylactic clip closure after endoscopic resection of large colon polyps
AU - Shah, Eric D.
AU - Pohl, Heiko
AU - Rex, Douglas K.
AU - Wallace, Michael B.
AU - Crockett, Seth D.
AU - Morales, Shannon J.
AU - Feagins, Linda A.
AU - Law, Ryan
N1 - Funding Information:
DISCLOSURE: Dr Law was a consultant for Olympus America and received royalties from UpToDate. Dr Rex was a consultant for Olympus Corporation, Boston Scientific, Medtronic, Aries, Braintree Laboratories; received research support from EndoAid , Olympus Corporation , Medivators , Erbe USA ; and has ownership in Satisfai Health. Dr Pohl received research grants from Boston Scientific , US Endoscopy , and Aries Pharmaceuticals . Dr Feagins, sponsored clinical research trial with Corona, Inc. Dr Crockett, clinical trial agreements/research support from Freenome, Guardant Health, Exact Sciences, ColoWrap; consulting for IngenioRx; general payments/minor food and beverage from Ferring Pharmaceuticals, Salix Pharmaceuticals, and Boston Scientific. Dr Wallace consulted for Virgo Inc, Cosmo/Aries Pharmaceuticals, Anx Robotica, Covidien; obtained research grants from Fujifilm , Boston Scientific, Olympus , Medtronic , Ninepoint Medical , Cosmo /Aries Pharmaceuticals; held stock options in Virgo, Inc; consulted on behalf of Mayo Clinic for GI Supply (2018), Endokey, Endostart, Boston Scientific, MicroTek; received general payments/minor food and beverages from Synergy Pharmaceuticals, Boston Scientific, Cook Medical. All other authors disclosed no financial relationships relevant to this publication.
Funding Information:
Dr Shah is supported by the AGA Research Foundation's 2019 AGA-Shire Research Scholar Award in Functional GI and Motility Disorders. Dr Feagins was supported by VA MERIT CX000815. Large Polyp Study Group Collaborators: Ian S. Grimm, Matthew T. Moyer, Muhammad K. Hasan, Douglas Pleskow, B. Joseph Elmunzer, Mouen A. Khashab, Omid Sanaei, Firas H. Al-Kawas, Stuart R. Gordon, Abraham Mathew, John M. Levenick, Harry R. Aslanian, Fadi Antaki, Daniel von Renteln, Amit Rastogi, Jeffrey A. Gill, Maria Pellise.
Funding Information:
DISCLOSURE: Dr Law was a consultant for Olympus America and received royalties from UpToDate. Dr Rex was a consultant for Olympus Corporation, Boston Scientific, Medtronic, Aries, Braintree Laboratories; received research support from EndoAid, Olympus Corporation, Medivators, Erbe USA; and has ownership in Satisfai Health. Dr Pohl received research grants from Boston Scientific, US Endoscopy, and Aries Pharmaceuticals. Dr Feagins, sponsored clinical research trial with Corona, Inc. Dr Crockett, clinical trial agreements/research support from Freenome, Guardant Health, Exact Sciences, ColoWrap; consulting for IngenioRx; general payments/minor food and beverage from Ferring Pharmaceuticals, Salix Pharmaceuticals, and Boston Scientific. Dr Wallace consulted for Virgo Inc, Cosmo/Aries Pharmaceuticals, Anx Robotica, Covidien; obtained research grants from Fujifilm, Boston Scientific, Olympus, Medtronic, Ninepoint Medical, Cosmo/Aries Pharmaceuticals; held stock options in Virgo, Inc; consulted on behalf of Mayo Clinic for GI Supply (2018), Endokey, Endostart, Boston Scientific, MicroTek; received general payments/minor food and beverages from Synergy Pharmaceuticals, Boston Scientific, Cook Medical. All other authors disclosed no financial relationships relevant to this publication.Dr Shah is supported by the AGA Research Foundation's 2019 AGA-Shire Research Scholar Award in Functional GI and Motility Disorders. Dr Feagins was supported by VA MERIT CX000815. Large Polyp Study Group Collaborators: Ian S. Grimm, Matthew T. Moyer, Muhammad K. Hasan, Douglas Pleskow, B. Joseph Elmunzer, Mouen A. Khashab, Omid Sanaei, Firas H. Al-Kawas, Stuart R. Gordon, Abraham Mathew, John M. Levenick, Harry R. Aslanian, Fadi Antaki, Daniel von Renteln, Amit Rastogi, Jeffrey A. Gill, Maria Pellise.
Publisher Copyright:
© 2020 American Society for Gastrointestinal Endoscopy
PY - 2020/6
Y1 - 2020/6
N2 - Background and Aims: Clip closure of the mucosal defect after resecting large (≥20 mm) nonpedunculated colorectal polyps reduces postprocedure bleeding and is cost saving for payers. Clip costs are not reimbursed by payers, posing a major barrier to adoption of this technique in the community. We aimed to determine appropriate clip costs to support broader use of this procedure in practice. Methods: We performed budget impact analysis using our recent decision analytic model, comparing prophylactic clip closure with no clip closure on national cost and outcomes data, to determine the maximum feasible clip price while maintaining cost savings in practice. Sensitivity analyses were performed on important clinical factors. Results: In the original model, the baseline postprocedure bleeding risk was 6.8%, increasing cost of care by $614.11 averaged among all patients undergoing large polyp resection without clip closure. Prophylactic clip closure of only large right-sided polyps reduced postprocedure bleeding risk by 70.7% but resulted in cost saving only if the price of clips was $100 or less. Comparatively, prophylactic clip closure of large left-sided polyps had no clinical benefit and was not cost saving. Clip closure strategies focused only on extra-large polyps (≥40 mm), or patients taking antithrombotics regardless of polyp characteristics, were only minimally cost saving. Cost savings and maximum tolerated clip prices depended on medical comorbidity, which directly influences the costs of care to manage postprocedure bleeding. Conclusions: Prophylactic clip closure after endoscopic resection of large colon polyps, particularly those in the right colon segment, is cost saving but requires clip costs less than $100. Translating these findings into practice requires gastroenterology practices to obtain reimbursement from payers for improved clinical outcomes and to align commercial clip prices with this clinical indication.
AB - Background and Aims: Clip closure of the mucosal defect after resecting large (≥20 mm) nonpedunculated colorectal polyps reduces postprocedure bleeding and is cost saving for payers. Clip costs are not reimbursed by payers, posing a major barrier to adoption of this technique in the community. We aimed to determine appropriate clip costs to support broader use of this procedure in practice. Methods: We performed budget impact analysis using our recent decision analytic model, comparing prophylactic clip closure with no clip closure on national cost and outcomes data, to determine the maximum feasible clip price while maintaining cost savings in practice. Sensitivity analyses were performed on important clinical factors. Results: In the original model, the baseline postprocedure bleeding risk was 6.8%, increasing cost of care by $614.11 averaged among all patients undergoing large polyp resection without clip closure. Prophylactic clip closure of only large right-sided polyps reduced postprocedure bleeding risk by 70.7% but resulted in cost saving only if the price of clips was $100 or less. Comparatively, prophylactic clip closure of large left-sided polyps had no clinical benefit and was not cost saving. Clip closure strategies focused only on extra-large polyps (≥40 mm), or patients taking antithrombotics regardless of polyp characteristics, were only minimally cost saving. Cost savings and maximum tolerated clip prices depended on medical comorbidity, which directly influences the costs of care to manage postprocedure bleeding. Conclusions: Prophylactic clip closure after endoscopic resection of large colon polyps, particularly those in the right colon segment, is cost saving but requires clip costs less than $100. Translating these findings into practice requires gastroenterology practices to obtain reimbursement from payers for improved clinical outcomes and to align commercial clip prices with this clinical indication.
UR - http://www.scopus.com/inward/record.url?scp=85083017715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083017715&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2020.01.018
DO - 10.1016/j.gie.2020.01.018
M3 - Article
C2 - 31962121
AN - SCOPUS:85083017715
SN - 0016-5107
VL - 91
SP - 1353
EP - 1360
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 6
ER -